Patiromer With or Without Food for the Treatment of Hyperkalemia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 114 participants.

Also called NCT02694744

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 114 participants (enrolled count) (from the registry)
Sponsor
  • Relypsa, Inc. Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02694744
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02694744. Randomized; no masking; primary purpose treatment. Start 2016-02 (registry gives no type); primary completion 2016-07 (actual). Results posted on 2017-11-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Patiromer With or Without Food for the Treatment of Hyperkalemia
Acronym
TOURMALINE
Condition
Hyperkalemia
Intervention (Drug)
patiromer
Lead sponsor
Relypsa, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02694744
Content hash
b48fdac830b45c28cfd842a9f0ce0dba5ae626c25c9b964c2f3abc57657d2aac